John I. Germershausen

Statistics

Publications

Citations

1.3K

H-Index

Active since

1965

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Merck Institute for Science Education

John I. Germershausen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in life sciences, biochemistry, and pharmacology.

Publications per year

1965–2008

Publications

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.

Anjalie Field, M E Davies, Corrille M. DeWitt et al. · Proceedings of the National Academy of Sciences · 1983 · 389 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo

John I. Germershausen, V. M. Hunt, Richard G. Bostedor et al. · Biochemical and Biophysical Research Communications · 1989 · 172 citations

Medicine, Cardiology, Pharmacology +11

HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.

Peter F. Smith, R. S. Eydelloth, Scott Grossman et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 147 citations

Medicine, Pharmacology, Pharmacotherapy +13

Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.

Douglas J. Kornbrust, J. S. Macdonald, C. P. Peter et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 97 citations

Veterinary Medicine, Pharmacology, Pharmacotherapy +17

Farnesol-derived Dicarboxylic Acids in the Urine of Animals Treated with Zaragozic Acid A or with Farnesol

Richard G. Bostedor, John D. Karkas, Byron H. Arison et al. · Journal of Biological Chemistry · 1997 · 67 citations · Full text

Medicine, Pharmacology, Biochemical Pharmacology +14

1–5 of 21